Dolutegravir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 25 mg, 50 mg
Reference Brands: Tivicay(Us & EU)
Category: Anti Viral
Dolutegravir is an HIV-1 treatment from the integrase inhibitor class that blocks viral replication. Approved by the US FDA and EMA, it is used alone or in combination therapies like Tivicay, Triumeq, and Dovato. Known for strong efficacy and once-daily dosing. Dolutegravir is available in Tablet and strengths such as 10 mg, 25 mg, 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dolutegravir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Dolutegravir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Dolutegravir is a potent antiretroviral drug used for the treatment of HIV-1 infection. As an integrase strand transfer inhibitor (INSTI), it blocks the enzyme HIV integrase, preventing viral replication. Dolutegravir is available as a standalone medication (brand name Tivicay) and in fixed-dose combinations like Triumeq, Dovato, and Juluca. Approved by the US FDA and EMA, it is used in both adults and children. Known for its once-daily dosing, high genetic barrier to resistance, and strong efficacy, Dolutegravir is a preferred first-line HIV therapy recommended by WHO and leading HIV treatment guidelines globally. Ideal for long-term HIV management.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dolutegravir is used for the treatment of HIV-1 infection. It helps reduce viral load, increase CD4 counts, and is often used as part of combination antiretroviral therapy. It is effective, well-tolerated, and widely used in first-line HIV treatment regimens.
Dolutegravir is made from the active substance dolutegravir sodium, which is an integrase strand transfer inhibitor (INSTI). It works by blocking the integrase enzyme that HIV needs to replicate.
The main trade name is Tivicay.
Tivicay is manufactured by ViiV Healthcare.
The generic name is Dolutegravir (commonly available as dolutegravir sodium).
The brand name is Tivicay.
It is manufactured in the UK and Europe by ViiV Healthcare, while licensed generic versions are produced in India by approved pharmaceutical manufacturers.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
